- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02239328
A Study of Patient-reported Outcomes in Patients With Lung or Esophageal Cancer
연구 개요
상세 설명
A patient-centered approach to lung cancer surveillance following resection needs to incorporate patient reported outcomes. The Patient Reported Outcomes Measurement Information System (PROMIS®) was designed to revolutionize the assessment of patient reported outcomes by establishing a national resource for the measurement of patient-reported symptoms and other health outcomes.
The PROMIS Assessment Center, the management tool within the larger PROMIS system, will be used to securely store de identified data, provide automated accrual reports and data export for this specific study. This study will have it's own study specific website.
Patients seen at the University of Virginia Cancer Center will be identified and invited to participate in an assessment of their reported outcomes over multiple domains available in PROMIS. Collecting this information on lung cancer survivors may provide a robust platform to design a patient-centered surveillance strategy following resection.
The study team hypothesizes that patient reported outcomes will vary according to the presence of recurrence or metastasis of lung or esophageal cancer. The study team also believes including patient reported outcomes into routine post-treatment surveillance will improve patient satisfaction and improve outcomes.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
Virginia
-
Charlottesville, Virginia, 미국, 22908
- University of Virginia
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- ≥18 years of age
- Suspected or Known diagnosis of lung or esophageal cancer
- Willing and able to complete questionnaires
Exclusion Criteria:
- Subjects unwilling to provide informed consent
- Subjects unwilling or unable to answer the questionnaires
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
|---|
|
Lung Cancer, Esophageal Cancer
Lung Cancer and Esophageal Cancer patients will complete the online PROMIS survey.
No treatment intervention will be performed.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Patient Reported Outcomes Measurement Information System (PROMIS) Scores.
기간: Over a 3 year period
|
Enrolled subjects with lung or esophageal cancer will be asked to complete an on-line (web-based) survey (PROMIS) using a computer.
Most patients will only be asked to complete this survey once, but some patients will be asked to answer the questions a second or third time over a maximum five year period.
The PROMIS assessment center was used to develop and administer patient reported outcomes (PROs) for each of these five cancer domains.
PROMIS scores are continuous and range from 0-100.
Total scores were calculated and calibrated to the weighted distribution of scores from a large representative sample of the U.S. general population using the 'T-score' algorithm 18.
The T-scores for the study population are calibrated to the surveyed population mean of 50 and standard deviation of 10, such that a study patient with a T-score of 40 is one standard deviation below the U.S. general population mean.
|
Over a 3 year period
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Benjamin Kozower, MD, University of Virginia
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .